We continually prove it’s possible to invent and advance affordable and effective medicines that prevent and treat diseases of poverty, like HIV, malaria, diarrheal disease, and infections—and to get them safely to people who need them.
Women want and need access to a variety of contraceptives to plan, space, and prevent pregnancies. PATH is expanding access and options with DMPA-SC (brand name Sayana® Press), an all-in-one contraceptive that puts women in charge of their reproductive health.
The world has changed in remarkable—even unprecedented—ways since PATH got its start. Now we're accelerating our efforts to create greater health, equity, and opportunity everywhere.
Access to oxygen should not be a matter of location or luck. The HO2PE campaign aims to bring the issue of oxygen access to the forefront of discussions on newborn, child and maternal health. Help PATH increase awareness about the importance of oxygen treatment and its impact on saving precious breath and life around the world by utilizing the campaign resources below.
How PATH is advancing new effective and affordable treatments for diarrhea and the underlying enteric infections that cause it.
Family planning leaders can draw from an established base of evidence to integrate DMPA-SC in efforts to address unmet need and increase access to contraception through a range of delivery channels.
Family planning advocates can ensure that a country’s policies and funding promote access to all contraceptive options, so women can make an informed and voluntary choice. The Advocacy Pack for Subcutaneous DMPA was designed for advocates around the globe to help increase access to this new injectable contraceptive option.